Eargo Inc
NASDAQ:EAR
Eargo Inc
Cash from Financing Activities
Eargo Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eargo Inc
NASDAQ:EAR
|
Cash from Financing Activities
$111.1m
|
CAGR 3-Years
178%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Eargo Inc's Cash from Financing Activities?
Cash from Financing Activities
111.1m
USD
Based on the financial report for Dec 31, 2022, Eargo Inc's Cash from Financing Activities amounts to 111.1m USD.
What is Eargo Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
52%
Over the last year, the Cash from Financing Activities growth was 2 449%. The average annual Cash from Financing Activities growth rates for Eargo Inc have been 178% over the past three years , 52% over the past five years .